Announced Mon, 12 Jan · 20:58 IST

as per attachment

Warrants ConvertedFund Raising View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.4%1-day move
₹44.50
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.4+4.5+3.4+3.4+6.7+4.8-9.0+6.7-7.9-1.7
Up moveDown movePending
AI summary

Vaxfab Enterprises has allotted 2,04,04,371 fully convertible warrants at Rs. 21.02 per warrant to 50 investors on a preferential basis, each convertible into one equity share within 18 months. Separately, 21,27,689 equity shares were allotted at Rs. 21.02 each (aggregating Rs. 4.47 crore) to 41 warrant holders upon conversion of previously issued warrants, with the balance Rs. 15.765 per share paid at the time of conversion. After these allotments, the company's paid-up equity share capital has risen to Rs. 10.52 crore, comprising 1,05,27,689 equity shares of Rs. 10 face value. The allotments were done on a preferential basis at a price significantly above face value.

Likely market impact

Shareholders face meaningful dilution with over 2.25 crore shares (warrants plus conversions) being added to the capital base. The fresh capital infusion may support business growth, but near-term stock sentiment could be pressured by the dilution overhang from the large outstanding warrants.